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Abstract  12 
The growth of potential probiotic strains from the genera Lactobacillus, 13 
Bifidobacterium and Streptococcus was evaluated with the novel lactose-derived 14 
trisaccharides 4’-galactosyl-kojibiose and lactulosucrose and the potential prebiotics 15 
lactosucrose and kojibiose. The novel oligosaccharides were synthesized from 16 
equimolar sucrose:lactose and sucrose:lactulose mixtures, respectively, by the use of a 17 
Leuconostoc mesenteroides dextransucrase and purified by liquid chromatography. The 18 
growth of the strains using the purified carbohydrates as the sole carbon source was 19 
evaluated by recording the culture optical density and calculating maximum growth 20 
rates and lag phase parameters. The results revealed an apparent bifidogenic effect of 21 
lactulosucrose, being also a moderate substrate for streptococci and poorlybut badly 22 
utilized by lactobacilli. In addition, 4’-galactosyl-kojibiose was selectively fermented by 23 
Bifidobacterium breve, which was also the only tested bifidobacterial species able to 24 
ferment kojibiose. The described fermentation properties of the specific probiotic strains 25 
on the lactose-derived oligosaccharides would enable the design of prebiotics with a 26 
high degree of selectivity. 27 
 28 
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1. Introduction 32 
The human large intestine is densely colonized by a complex microbial ecosystem that 33 
plays a key role in human health and disease, being the subject of intensive studies for 34 
its characterization during last years (Aagaard et al. 2013; Qin et al. 2010). Intestinal 35 
bacteria provide a diverse range of biochemical and metabolic activities to complement 36 
host physiology and exert numerous protective effects by modulating mucosal and 37 
systemic immune responses (Clemente, Ursell, Parfrey, & Knight, 2012). Among the 38 
metabolic functions, the fermentation of dietary components, which are principally 39 
undigested fibre carbohydrates, and the impact on the composition and/or activity of the 40 
human gut microbiota are attracting considerable attention in food and nutrition 41 
research (Roberfroid et al. 2010).  42 
Prebiotics are normally non-digestible dietary carbohydrates which are 43 
selectively fermented, resulting in specific changes in the composition and/or activity of 44 
a limited number of intestinal bacteria, thus conferring benefit(s) upon host health 45 
(Roberfroid et al. 2010). Currently, there are certain carbohydrates with well-known 46 
prebiotic status, and these include lactulose, inulin, fructo-oligosaccharides, galacto-47 
oligosaccharides and resistant starch (Di Bartolomeo, Startek, & Van den Ende, 2013; 48 
Slavin, 2013). However, over the last decades there has been a growing search for new 49 
prebiotic carbohydrates which could be considered as emerging prebiotics, such as xylo-50 
oligosaccharides, arabinoxylo-oligosaccharides, isomalto-oligosaccharides, lactosucrose 51 
and pectic-oligosaccharides, among others (Rastall & Gibson, 2002). Likewise, 52 
significant research efforts are currently focused on the search and/or production of 53 
novel prebiotic ingredients that have a series of desirable properties including: i) to be 54 
active at low dosage, ii) lack of side effects, iii) persistence through the colon, iv) fine 55 
control of microbiota modulation, v) good storage and processing stability and vi) to 56 
4 
 
possess additional biological activities, exerting beneficial effects on specific 57 
physiological functions and/or reducing the risk of disease, for example, through their 58 
effect on displacement of pathogens and/or regulation of the function of the immune 59 
system (Rastall & Hotchkiss, 2003). In this context, we have recently described the 60 
efficient dextransucrase-catalyzed synthesis of oligosaccharides such as lactulosucrose 61 
(Díez-Municio, Herrero, Jimeno, Olano, & Moreno, 2012a) and 2-α-glucosyl-lactose, 62 
also denominated 4’-galactosyl-kojibiose (Díez-Municio et al., 2012b), whose structural 63 
features makes them promising candidates for novel prebiotic ingredients. Nevertheless, 64 
to the best of our knowledge, no data on selective fermentation by bacteria have been 65 
reported for these novel oligosaccharides. In addition, high-yield and high high-purity 66 
kojibiose has been recently obtained from the complete hydrolysis Kluyveromyces lactis 67 
-galactosidase hydrolysis of 4’-galactosyl-kojibiose by Kluyveromyces lactis -68 
galactosidase (Díez-Municio, Montilla, Moreno, & Herrero, 2014). Kojibiose is a 69 
natural disaccharide commercially available only in low amounts due to different 70 
drawbacks in related to its isolation and/or synthesis. Nevertheless, available scarce data 71 
already available have pointed out kojibiose to have a promising prebiotic potential 72 
(Sanz, Gibson, & Rastall, 2005).  73 
In this work, the ability of kojibiose and novel lactose-derived oligosaccharides, 74 
i.e. 4’-galactosyl-kojibiose and lactulosucrose, to be metabolized by pure cultures of 75 
potential probiotic strains belonging to the genera Lactobacillus, Bifidobacterium and 76 
Streptococcus is evaluated and compared with well-established (lactulose) or emerging 77 
(lactosucrose) lactose-derived prebiotics. Considering that there is a strong link between 78 
the oligosaccharide chemical structure and its potential bioactivities, the results derived 79 
from this study could provide further insights into the influence of the monomer 80 
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composition and glycosidic linkage type on the selective fermentability of lactose-81 
derived oligosaccharides by specific probiotic strains. 82 
 83 
2. Materials and methods 84 
2.1. Chemicals, reagents, standards and enzymes 85 
All used chemicals and reagents were of analytical grade, purchased from Sigma-86 
Aldrich (St. Louis, MO, USA), VWR (Barcelona, Spain), and Merck (Darmstadt, 87 
Germany). Ultra-pure water quality (18.2 MΩcm) with 1–5 ppb total organic carbon 88 
(TOC) and <0.001 EU mL
-1
 pyrogen levels was produced in-house using a laboratory 89 
water purification Milli-Q Synthesis A10 system from Millipore (Billerica, MA, USA).  90 
Carbohydrates (fructose, glucose, galactose, sucrose, leucrose, lactulose and 91 
lactose) were all provided from Sigma-Aldrich (St. Louis, MO, USA), standard 92 
kojibiose was purchased from Carbosynth (Berkshire, UK) and lactosucrose from Wako 93 
Pure Chemical Industries (Osaka, Japan).  94 
Dextransucrase from Leuconostoc mesenteroides B-512F was purchased from 95 
CRITT Bio-Industries (Toulouse, France). Specific activity was 0.4 U mg
−1
, where 1 U 96 
is the amount of enzyme required to perform the transfer of 1 μmol of glucose per 97 
minute at a working temperature of 30 °C, a sucrose concentration of 100 g L
-1
 at pH 98 
5.2 in 20 mM sodium acetate buffer with 0.34 mM of CaCl2. Soluble commercial 99 
preparation of -galactosidase from K. lactis (Lactozym Pure 6500 L) was kindly 100 
supplied by Novozymes (Bagsvaerd, Denmark). 101 
 102 
2.2. Synthesis, purification and characterization of the studied oligosaccharides 103 
The trisaccharide lactulosucrose, β-D-galactopyranosyl-(1→4)-β-D-fructofuranosyl-104 
(2→1)-α-D-glucopyranoside, was enzymatically synthetized synthesized from 105 
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sucrose:lactulose mixtures by the L. mesenteroides B-512F dextransucrase-catalyzed 106 
transfer of the glucosyl residue from sucrose to the C-2- hydroxyl group of the reducing 107 
unit of lactulose as described by Díez-Municio, Herrero, Jimeno, Olano, & Moreno 108 
(2012a). The enzymatic reaction was carried out with 30% (w/v) of sucrose and 30% 109 
(w/v) of lactulose and an enzyme charge of 2.4 U mL
-1
 at 30 ºC in 20 mM sodium 110 
acetate buffer with 0.34 mM CaCl2 (pH 5.2) during 24 h of reaction time. Under these 111 
optimal conditions, lactulosucrose yield was around 30% in weight respect to the initial 112 
amount of lactulose. 113 
The enzymatic synthesis of the trisaccharide 4’-galactosyl-kojibiose also termed 114 
as 2-α-D-glucopyranosyl-lactose, O-β-D-galactopyranosyl-(1→4)-O-α-D-115 
glucopyranosyl-(2→1)-α-D-glucopyranose), also termed as 2-α-D-glucopyranosyl-116 
lactose was carried out in the presence of sucrose (donor) and lactose as acceptor 117 
(30:30, expressed in g/100 mL), in 20 mM sodium acetate buffer with 0.34 mM CaCl2 118 
(pH 5.2) at 30 ºC using a L. mesenteroides B-512F dextransucrase (0.8 U mL
-1
) as 119 
described by Díez-Municio et al. (2012b). The optimal synthesis conditions at 24 h of 120 
enzymatic reaction gave rise to yields around close to 50% (in weight respect to the 121 
initial amount of lactose). 122 
Kojibiose (2-O-α-D-glucopyranosyl-α-D-glucopyranose) was obtained from the 123 
hydrolysis of 4’-galactosyl-kojibiose by K. lactis β-galactosidase, after removal of 124 
residual monosaccharides by using a Saccharomyces cerevisiae treatment and further 125 
purification as described by Díez-Municio, Montilla, Moreno, & Herrero (2014). 126 
Isolation of pure oligosaccharides was performed by liquid chromatography with 127 
refractive index detector (LC-RID) on an Agilent Technologies 1260 Infinity LC 128 
System (Boeblingen, Germany) using a Zorbax NH2 PrepHT preparative column (250 × 129 
21.2 mm, 7 µm particle size) (Agilent Technologies, Madrid, Spain). Two mL of 130 
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reaction mixtures (150 200 mg of total carbohydrates) were eluted with 131 
acetonitrile:water as the mobile phase at a flow rate of 21.0 mL min
-1 
for 30 min. The 132 
separated oligosaccharides were collected using an Agilent Technologies 1260 Infinity 133 
preparative-scale fraction collector (Boeblingen, Germany), and the fractions were 134 
pooled, evaporated in a rotatory evaporator R-200 (Büchi Labortechnik AG, Flawil, 135 
Switzerland) below 25 ºC and freeze-dried. Purity grade was in all cases ≥ 99.0% as 136 
checked by LC-RID. 137 
Lactulosucrose and 4’-galactosyl-kojibiose were then fully characterized by 1D 138 
and 2D [
1
H, 
1
H] and [
1
H-
13
C] nuclear magnetic resonance (NMR) experiments 139 
(gCOSY, TOCSY, ROESY, multiplicity-edited gHSQC and gHMBC) (Díez-Municio, 140 
Herrero, Jimeno, Olano, & Moreno, 2012a; Díez-Municio et al., 2012b), whilst 141 
kojibiose was identified by LC-RID and gas chromatography with mass spectrometry 142 
detection (GC-MS) analyses by comparison with a commercial standard (Díez-Municio, 143 
Montilla, Moreno, & Herrero, 2014).  144 
 145 
2.3. Bacterial strains and culture media 146 
Streptococcus salivarius ZL50-7, Lactobacillus reuteri R13, Lactobacillus delbrueckii 147 
ZL95-27, Bifidobacterium breve 26M2 and Bifidobacterium bifidum HDD541 were 148 
isolated from milk of healthy mothers or infant feces and belong to the culture 149 
collection of the Department of Nutrition and Food and Science Technology, 150 
Universidad Complutense de Madrid (Madrid, Spain). Streptococcus thermophilus 151 
STY-31, Lactobacillus acidophilus LA-5, Lactobacillus casei LC-01 and 152 
Bifidobacterium lactis BB-12 were isolated from a commercial symbiotic product 153 
(Simbiotic Drink, Priégola, Madrid, Spain) as described by Tabasco, Paarup, Janer, 154 
Peláez, & Requena (2007). Lactobacillus rhamnosus GR-1 is a commercial probiotic 155 
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strain isolated from the human urogenital tract (Chan, Bruce, & Reid, 1984). Before 156 
being used in experiments, all strains were routinely cultured in MRS broth (Pronadisa, 157 
Madrid, Spain), except for S. salivarius ZL50-7 and S. thermophilus STY-31 that were 158 
grown in ESTY broth (Pronadisa) containing 20 g/L lactose (ESTY-L).  159 
Basic media for experiments were MRS fermentation broth (Pronadisa), which 160 
does not contain either glucose or meat extract (De Man, Rogosa, & Sharpe, 1960), 161 
enriched with 0.2% Tween 80, 0.8% casein acid hydrolysate and 0.05% L-cysteine, or 162 
ESTY broth (Pronadisa), without any carbon source. These media were supplemented 163 
with the tested oligosaccharides at a final concentration of 0.3% (w/v). Each substrate 164 
was weighed and then added to the corresponding autoclaved basic media, and the 165 
mixtures were filter sterilized with 0.2-µm-pore-size sterile filters. Glucose and 166 
lactulose were used as control of growth, being added at the same final concentration as 167 
the corresponding experimental oligosaccharides. Additional controls were made with 168 
basic medium and without carbon source and were incubated with each strain tested. 169 
 170 
2.4. Evaluation of bacterial growth on synthesized carbohydrates 171 
The bacterial strains were cultured overnight at 1% in MRS or ESTY-L broth, 172 
depending on the strain. The cells were harvested by centrifugation (10,000 × g for 10 173 
min at 4 ºC), washed twice with and resuspended in sterile saline solution (0.85%), and 174 
inoculated (1%) into the basic media plus the tested carbohydrate. Bacterial growth was 175 
monitored in duplicate 300 µL-wells of sterile 96-well microplates with lid (Sarstedt, La 176 
Roca del Vallès, Spain). All strains were grown in aerobic conditions at 37 °C for 48 h, 177 
with the exception of the Bifidobacterium strains. The optical densities at 600 nm 178 
(OD600) of the strains growing aerobically were recorded at 60 min intervals with an 179 
automated microplate reader (Varioskan Flash, Thermo Fisher Scientific, Waltham, 180 
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MA, USA), at duplicate experiments. Maximum growth rates (μmax) and lag parameter 181 
(lag) of strains growing under aerobic conditions were calculated by fitting the curves to 182 
a sigmoid model using the Microsoft Excel add-in DMfit v.2.1 (Barayni & Roberts, 183 
1994) (available at http://www.ifr.ac.uk/safety/DMfit/default.html). In the case of the 184 
anaerobic strains, B. breve 26M2, B. lactis BB-12 and B. bifidum HDD541, microplates 185 
were kept at an anaerobic incubator at 37 °C for 48 h (Bactron Anaerobic Chamber; 186 
Sheldon Manufacturing, Cornelius, OR, USA). The OD600 was recorded at the 187 
microplate reader at 0 h, 24 h and 48 h.  188 
 189 
3. Results 190 
The structures of the tested oligosaccharides, including the commercially available 191 
lactulose and lactosucrose are depicted in Fig. 1. Kojibiose, 4’-Ggalactosyl-kojibiose 192 
and lactulosucrose were synthesized from equimolar sucrose:lactose and 193 
sucrose:lactulose mixtures, respectively, by using a L. mesenteroides B-512F 194 
dextransucrase which catalyzed the transfer of the glucosyl residue from sucrose to the 195 
2-hydroxyl group of the reducing unit of lactose and lactulose, respectively (Díez-196 
Municio, Herrero, Jimeno, Olano, & Moreno, 2012a; Díez-Municio et al., 2012b). 197 
Additionally, tThe synthesis of kojibiose from 4’-galactosyl-kojibiose required 198 
additional stages such as monosaccharide removal and -galactosidase hydrolysis 199 
before chromatographic purification (Díez-Municio, Montilla, Moreno, & Herrero, 200 
2014).  201 
Maximum optical densities at 600 nm (ODmax), maximum growth rates (µmax) 202 
and lag times (h) during growth of the strains under aerobic conditions on the assayed 203 
oligosaccharides are shown in Table 1. As expected, all strains grew well on glucose, 204 
reaching L. rhamnosus GR-1 the highest ODmax and L. reuteri R13 the highest µmax 205 
10 
 
values. Overall, the registered bacterial growth parameters registered were lower with 206 
lactulose than with glucose, showing both L. delbrueckii ZL95-27 and L. acidophilus 207 
LA-5 no growth on lactulose. Among the synthesized carbohydrates, none of the strains 208 
tested under aerobic conditions did growgrew with 4’-galactosyl-kojibiose as carbon 209 
source and only the Streptococcus strains grew on lactulosucrose (Table 1). Kojibiose 210 
and lactosucrose promoted the growth of five and four bacterial strains, respectively, out 211 
of the seven tested strains (Fig. 2). Main differences between strains when growing on 212 
lactosucrose were observed for lag times, with the shortest time registered for L. casei 213 
(5.75 h) and longer lag times (31.82 h and 40.20 h) for L. reuteri R13 and L. 214 
acidophilus LA-5. On the other hand, except for L. acidophilus LA-5, lag times of the 215 
strains growing on kojibiose were similar and shorter than 5 h, with the highest ODmax 216 
value recorded for L. rhamnosus GR-1. This strain was characterized by growing on the 217 
assayed disaccharides lactulose and kojibiose but not utilizing the tested trisaccharides 218 
as carbon sources (Table 1).    219 
Regarding the Bifidobacterium strains, OD600 could not be recorded 220 
continuously at 60 min intervals due to the required anaerobic growth conditions of the 221 
species. The OD600 values after 24 h and 48 h growth of B. lactis BB-12, B. breve 26M2 222 
and B. bifidum HDD541 with the six carbohydrates used as carbon sources are shown in 223 
Table 2. Lactulosucrose was fermented by the three bifidobacterial strains, which 224 
reached at 24h  higher cell densities than when growing with lactosucrose or lactulose, 225 
and being also the only oligosaccharide fermented by B. bifidum HDD541. Remarkably, 226 
B. breve 26M2 was the only strain among the bacteria assayed that was able to growth 227 
with all the tested carbohydrates and particularly with kojibiose and 4’-galactosyl-228 
kojibiose. In the case of B. lactis BB-12, it exhibited growth on lactulose, lactosucrose 229 
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and lactulosucrose, although no growth was observed on kojibiose and 4’-galactosyl-230 
kojibiose.  231 
 232 
4. Discussion 233 
This article reports important differences in the ability of the studied lactose-derived 234 
oligosaccharides to promote the growth of representative probiotic strains from three 235 
different genera (Lactobacillus, Bifidobacterium and Streptococcus). These results 236 
highlight the key role played by the monomer composition, molecular weight and 237 
glycosidic linkage on their fermentable properties, as well as reinforce the fact that the 238 
ability to metabolize particular carbohydrates is species- and strain-dependent (de Vrese 239 
& Schrezenmeir, 2008).  240 
Among the tested carbohydrates, lactulose and lactosucrose are commercially 241 
available prebiotics, and kojibiose has also been described as a potential prebiotic (Sanz, 242 
Gibson, & Rastall, 2005), ). although However, the low availability and high cost of 243 
kojibiose impairs its use and explains the lack of studies on its bioactive properties 244 
(Díez-Municio, Montilla, Moreno, & Herrero, 2014). Regarding lactulosucrose and 4’-245 
galactosyl-kojibiose, to the best of our knowledge, no data on their prebiotic properties 246 
had been described so far in the literature. In this study, lactulosucrose had an apparent 247 
bifidogenic effect, being also a moderate substrate for streptococci and poorlybut badly 248 
utilized by lactobacilli. In contrast, lactosucrose allowed the growth of some strains of 249 
lactobacilli and bifidobacteria (Tables 1 and 2). By comparing both structures (Fig. 1), 250 
i.e. β-D-Gal-(1→4)-β-D-Fru-(2→1)-α-D-Glc vs β-D-Gal-(1→4)- -D-Glc-(1→2)- -D-251 
Fru, it can be inferred that monomer position might play an important role on the 252 
fermentation properties of oligosaccharides. Lactosucrose has proven to be scarcely 253 
hydrolyzed by human digestive enzymes (Fujita et al., 1991) and selectively utilized by 254 
12 
 
intestinal Bifidobacterium (Fujita, Ito, & Kishino, 2009; Ohkusa, Ozaki, Sato, Mikuni, 255 
& Ikeda, 1995; Takei, Akakura, Ueda, Mikami, & Ito, 2006), warranting its use as a 256 
prebiotic ingredient (Mu, Chen, Wang, Zhang, & Jiang, 2013). Although more 257 
information and further experiments are needed, considering the results reported in this 258 
work, lactulosucrose might also present a great potential as prebiotic, specially targeted 259 
to the growth of bifidobacteria (Table 2). Moreover, having lactulose as a core structure, 260 
lactulosucrose might possess the beneficial properties attributed to lactulose, e.g. 261 
prebiotic activity, enhancement of mineral absorption, blood glucose lowering effects 262 
and reduction in intestinal transit time, among others (Schuman, 2002). Lastly, since 263 
longer carbohydrate chains are normally fermented at slower rates (Perrin, Fougnies, 264 
Grill, Jacobs, & Schneider, 2002; Gibson, Probert, Van Loo, Rastall, & Roberfroid, 265 
2004), lactulosucrose might also exhibit lower fermentation rates as compared to 266 
lactulose, which would increase the interest as a novel prebiotic by increasing 267 
promoting its capacity to reach the distal parts of the colon.  268 
A valuable result obtained from this study is the selective fermentation of 4’-269 
galactosyl-kojibiose by B. breve 26M2 (Tables 1 and 2). Nakada, Nishimoto, Chaen, & 270 
Fukuda, (2003) evaluated the utilization by several intestinal bacteria of two koji-271 
oligosaccharides (degree of polymerization 3 and 4) linked with only α-1,2 glucosidic 272 
linkages and, in good agreement with data reported for 4’-galactosyl-kojibiose, they did 273 
not observe any growth on four Lactobacillus strains (L. acidophilus, L. gasseri, L. 274 
reuteri and L. salivarius), although both koji-oligosaccharides strongly enhanced 275 
growth of B. breve. In addition, B. breve 26M2 selectively utilized kojibiose, which was 276 
also a good substrate for lactobacilli (Tables 1 and 2), confirming the prebiotic potential 277 
of the disaccharide stated by Sanz, Gibson, & Rastall, et al. (2005). Similarly, Nakada, 278 
Nishimoto, Chaen, & Fukuda, (2003) observed a good utilization of kojibiose by B. 279 
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breve but not by B. bifidum. O’Connel et al. (2013) have recently demonstrated the 280 
presence in B. breve of a distinctive α-glucosidase (MelD) with α-(1→2)-glycosyl 281 
hydrolase activity that could be involved in the hydrolysis of the disaccharide. A 282 
considerable variability in the carbohydrate metabolic abilities has been described 283 
between bifidobacterial strains (Hopkins, Cummings, & Macfarlane, 1998; Pokusaeva, 284 
Fitzgerald, & van Sinderen, 2011). In fact, the increasing access to bifidobacteria 285 
genome sequences has revealed that these organisms contain several oligosaccharide 286 
uptake systems and carbohydrate-hydrolyzing enzymes, sugar ABC 287 
(ATP Binding Cassette) transporters or PEP-PTS (phosphoenolpyruvate-288 
phosphotransferase system) components, that vary between species (Macfarlane, 289 
Blackett, & Macfarlane, 2010; Pokusaeva, Fitzgerald, & van Sinderen, 2011).  290 
 291 
5. Conclusions 292 
In conclusion, findings reported in this work point out the selective fermentation 293 
properties of a series of emerging or novel lactose-derived oligosaccharides on specific 294 
probiotic strains. Although pure culture models do not reflect bacterial interactions in 295 
the host (Roberfroid, 2007; Watson et al., 2012), this type of assays is adequate for 296 
screening studies aimed to the initial selection of non-digestible carbohydrates that 297 
would be able to selectively enrich probiotic strains within the gut microbiota diversity, 298 
and to assist in the design of prebiotics with a high degree of selectivity. In addition, 299 
these results provide new or additional evidences for further investigation of the 300 
potential effects of these oligosaccharides on the diversity and/or activity of the gut 301 
microbiota, as well as on the metabolic consequences for the host. 302 
 303 
Acknowledgements 304 
14 
 
This work has been supported by projects AGL2011-27884, AGL2012-35814, 305 
RM2011-00003-00-00 and Consolider Ingenio 2010 FUN-C-FOOD -306 
 and project POII10-0178-4685 from Junta de 307 
Comunidades de Castilla-La Mancha and European Regional Development Fund 308 
(ERDF). The authors are participant in the COST Action FA1005 INFOGEST. M. 309 
Díez-Municio is supported by CSIC through JAE-Pre Programme co-funded by 310 
European Social Fund (ESF). M. Herrero thanks MICINN for his “Ramón y Cajal” 311 
contract. Authors thank Ramiro Martínez (Novozymes Spain, S.A.) for Lactozym 312 
supply.  313 
 314 
References 315 
Aagaard, K., Petrosino, J., Keitel, W., Watson, M., Katancik, J., Garcia, N., Patel, S., 316 
Cutting, M., Madden, T., Hamilton, H., Harris, E., Gevers, D., Simone, G., 317 
McInnes, P., & Versalovic, J. (2013). The Human Microbiome Project strategy 318 
for comprehensive sampling of the human microbiome and why it matters. The 319 
FASEB Jornal, 27, 1012–1022. 320 
Barayni, J., & Roberts, T.A. (1994). A dynamic approach to predicting bacterial growth 321 
in food. International Journal of Food Microbiology, 23, 277–294. 322 
Chan, R.C., Bruce, A.W., & Reid, G. (1984). Adherence of cervical, vaginal and distal 323 
urethral normal microbial flora to human uroepithelial cells and the inhibition of 324 
adherence of gram-negative uropathogens by competitive exclusion. Journal of 325 
Urology, 131, 596–601. 326 
Clemente, J.C., Ursell, L.K., Parfrey, L.W., & Knight, R. (2012). The impact of the gut 327 
microbiota on human health: an integrative view. Cell, 148, 1258–1270. 328 
15 
 
De Man, J.C., Rogosa, M., & Sharpe, E. (1960). A medium for the cultivation of 329 
lactobacilli. Journal of Applied Bacteriology, 23, 130–135. 330 
De Vrese, M., & Schrezenmeir, J. (2008). Probiotics, prebiotics, and synbiotics. 331 
Advanves in Biochemical Engineering/Biotechnology, 111, 1–66. 332 
Di Bartolomeo, F., Startek, J.B., & Van den Ende, W. (2013). Prebiotics to fight 333 
diseases: Reality or fiction? Phytotherapy Research, 27, 1457-1473. 334 
Díez-Municio, M., Herrero, M., Jimeno, M.L., Olano, A., & Moreno, F.J. (2012a). 335 
Efficient synthesis and characterization of lactulosucrose by Leuconostoc 336 
mesenteroides B-512F dextransucrase. Journal of Agricultural and Food 337 
Chemistry, 60, 10564–10571. 338 
Díez-Municio, M., Montilla, A., Jimeno, M.L., Corzo, N., Olano, A., & Moreno, F.J. 339 
(2012b). Synthesis and characterization of a potential prebiotic trisaccharide from 340 
cheese whey permeate and sucrose by Leuconostoc mesenteroides dextransucrase. 341 
Journal of Agricultural and Food Chemistry,60, 1945–1953. 342 
Díez-Municio, M., Montilla, A., Moreno, F.J., & Herrero, M. (2014). A sustainable 343 
biotechnological process for the efficient synthesis of kojibiose. Green Chemistry 344 
in press DOI: 10.1039/C3GC42246A  345 
Fujita, K., Ito, T., & Kishino, E. (2009). Characteristics and applications of 346 
lactosucrose. Proceedings of the Research Society of Japan Sugar Refineries' 347 
Technologists, 57, 13–21. 348 
Fujita, K., Osawa, T., Mikuni, K., Hara, K., Hashimoto, & H., Kitahara, S. (1991). 349 
Production of lactosucrose by β-fructofuranosidase and some of its physical 350 
properties. Journal of the Japanese Society of Starch Science, 38, 1–7. 351 
Con formato: Español (alfab.
internacional)
16 
 
Gibson, G.R., Probert, H.M., Van Loo, J., Rastall, R.A., & Roberfroid, M.B. (2004). 352 
Dietary modulation of the human colonic microbiota: updating the concept of 353 
prebiotics. Nutrition Research Reviews, 17, 259–275. 354 
Hopkins, M.J., Cummings, J.H., & Macfarlane, G.T. (1998). Inter-species differences in 355 
maximum specific growth rates and cell yields of bifidobacteria cultured on 356 
oligosaccharides and other simple carbohydrate sources. Journal of Applied 357 
Microbiology, 85, 381–386. 358 
Macfarlane, S., Blackett, K.E., & Macfarlane, G.T. (2010). Synthesis and utilization of 359 
exopolysaccharides and prebiotics. In B. Mayo, & D. van Sinderen (Eds.),  360 
Bifidobacteria: Genomics and Molecular Aspects (pp. 175-194). Norfolk, UK: 361 
Caister Academic Press.  362 
Mu, W., Chen, Q., Wang, X., Zhang, T., & Jiang, B. (2013), Current studies on 363 
physiological functions and biological production of lactosucrose. Applied 364 
Microbiology and Biotechnology, 97, 7073–7080. 365 
Nakada, T., Nishimoto, T., Chaen, H., & Fukuda, S. (2003), Kojioligosaccharides: 366 
Application of kojibiose phosphorylase on the formation of various 367 
kojioligosaccharides. In: G. Eggleston, & G. L. Co (Eds.), Oligosaccharides in 368 
Food and Agriculture (pp. 104–117). Washington DC: ACS Symposium Series, 369 
American Chemical Society.  370 
O'Connell, K.J., O'Connell, Motherway, M., O'Callaghan, J., Fitzgerald, G.F., Ross, 371 
R.P., Ventura, M., Stanton, C., & van Sinderen, D. (2013). Metabolism of four α-372 
glycosidic linkage-containing oligosaccharides by Bifidobacterium breve 373 
UCC2003. Applied and Environmental Microbiology, 79, 6280–6292. 374 
17 
 
Ohkusa, T., Ozaki, Y., Sato, C., Mikuni, K., & Ikeda, H. (1995). Long-term ingestion of 375 
lactosucrose increases Bifidobacterium sp. in human fecal flora. Digestion, 56, 376 
415–420. 377 
Perrin, S., Fougnies, C., Grill, J.P., Jacobs, H., & Schneider, F. (2002). Fermentation of 378 
chicory fructo-oligosaccharides in mixtures of different degrees of polymerization 379 
by three strains of bifidobacteria. Canadian Journal of Microbiology, 48, 759–380 
763. 381 
Pokusaeva, K., Fitzgerald, G.F., & van Sinderen, D. (2011). Carbohydrate metabolism 382 
in Bifidobacteria. Genes & Nutrition, 6, 285–306. 383 
Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., 384 
Pons, N., Levenez, F., Yamada, T., Mende, D.R., Li, J., Xu, J., Li, S., Li, D., Cao, 385 
J., Wang, B., Liang, H., Zheng, H., Xie, Y., Tap, J., Lepage, P., Bertalan, M., 386 
Batto, J.M., Hansen, T., Le Paslier, D., Linneberg, A., Nielsen, H.B., Pelletier, E., 387 
Renault, P., Sicheritz-Ponten, T., Turner ,K., Zhu, H., Yu, C., Li, S., Jian, M., 388 
Zhou, Y., Li, Y., Zhang, X., Li, S., Qin, N., Yang, H., Wang, J., Brunak, S., Doré, 389 
J., Guarner, F., Kristiansen, K., Pedersen, O., Parkhill, J., Weissenbach, J., 390 
MetaHIT Consortium, Bork, P., Ehrlich, S.D., & Wang, J. (2010). A human gut 391 
microbial gene catalogue established by metagenomic sequencing. Nature, 464, 392 
59–65.   393 
Rastall, R.A., & Gibson, G.R. (2002). Prebiotic oligosaccharides: evaluation of 394 
biological activities and potential future developments. In G.W. Tannock (Eds.), 395 
Probiotics and Prebiotics: Where are we going? (pp. 107-148). Wymondham, 396 
UK: Caister Academic Press. 397 
Rastall, R.A., & Hotchkiss, A.T. (2003). Potential for the development of prebiotic 398 
oligosaccharides from biomass. In G. Eggleston, G.L. Co (Eds.), 399 
Con formato: Español (alfab.
internacional)
18 
 
Oligosaccharides in Food and Agriculture (pp. 44-53). Washington DC: ACS 400 
Symposium Series, American Chemical Society.  401 
Roberfroid, M. (2007). Prebiotics: The concept revisited. Journal of Nutrition, 137, 402 
830S–837S. 403 
Roberfroid , M., Gibson, G.R., Hoyles, L., McCartney, A.L., Rastall, R., Rowland, I., 404 
Wolvers, D., Watzl, B., Szajewska, H., Stahl, B., Guarner, F., Respondek, F., 405 
Whelan, K., Coxam, V., Davicco, M.J., Léotoing, L., Wittrant, Y., Delzenne, 406 
N.M., Cani, P.D., Neyrinck, A.M., & Meheust, A. (2010). Prebiotic effects: 407 
metabolic and health benefits. British Journal of Nutrition, 104, S1–S63. 408 
Sanz, M.L., Gibson, G.R., & Rastall, R.A. (2005). Influence of disaccharide structure 409 
on prebiotic selectivity in vitro. Journal of Agricultural and Food Chemistry, 53, 410 
5192–5199. 411 
Schumann, C. (2002). Medical, nutritional and technological properties of lactulose. An 412 
update. European Journal of Nutrition, 41, I17–I25. 413 
Slavin, J. (2013). Fiber and prebiotics: mechanisms and health benefits. Nutrients, 22, 414 
1417-1435. 415 
Tabasco, R., Paarup, T., Janer, C., Peláez, C., & Requena, T. (2007). Selective 416 
enumeration and identification of mixed cultures of Streptococcus thermophilus, 417 
Lactobacillus delbrueckii subsp. bulgaricus, L. acidophilus, L. paracasei and 418 
Bifidobacterium lactis in fermented milk. International Dairy Journal, 17, 1107–419 
1114. 420 
Takei, K., Akakura, K., Ueda, T., Mikami, K., & Ito, H. (2006). Effect of oral 421 
lactosucrose supplementation on human enteric oxalate-degrading bacteria. 422 
Hinyokika Kiyo, 52, 687–691. 423 
Con formato: Español (alfab.
internacional)
19 
 
Watson, D., O'Connell, Motherway, M., Schoterman, M.H.C., Joost van Neerven, R.J., 424 
Nauta, A., & van Sinderen, D. (2012). Selective carbohydrate utilization by  425 
lactobacilli and bifidobacteria. Journal of Applied Microbiology, 114, 1132–1146. 426 
 427 
 428 
20 
 
Table 1. Maximum optical density at 600 nm (ODmax), maximum growth rate (μmax, h
−1
) and lag (h) parameters of bacteria growing under 429 
aerobic conditions on glucose, lactulose, lactosucrose and synthesized oligosaccharides as carbon sources. 430 
 431 
Species 
 
Glucose Lactulose Lactosucrose Kojibiose Lactulosucrose 4’-galactosyl-
kojibiose 
S. thermophilus STY-31 
ODmax 1.09 ± 0.03 0.73 ± 0.01 NG NG 0.47 ± 0.03 NG 
µmax 0.29 ± 0.02 0.08 ± 0.01   0.01 ± 0.00  
lag 1.74 ± 0.01 2.50 ± 0.06   11.52 ± 3.82  
S. salivarius ZL50-7 
ODmax 1.12 ± 0.01 1.09 ± 0.01 0.93 ± 0.01 0.84 ± 0.02 0.48 ± 0.06 NG 
µmax 0.49 ± 0.01 0.42 ± 0.01 0.13 ± 0.01 0.07 ± 0.01 0.01 ± 0.00  
lag 5.75 ± 0.04 7.46 ± 0.02 21.95 ± 0.11 4.62 ± 0.10 15.11 ± 1.85  
L. reuteri R13 
ODmax 1.09 ± 0.01 0.62 ± 0.01 0.51 ± 0.01 0.73 ± 0.01 NG NG 
µmax 0.54 ± 0.01 0.09 ± 0.00 0.05 ± 0.01 0.12 ± 0.01   
lag 1.69 ± 0.02 0.96 ± 0.01 31.82 ± 1.22 0.84 ± 0.08   
L. delbrueckii ZL95-27 
ODmax 0.67 ± 0.01 NG NG NG NG NG 
µmax 0.14 ± 0.00      
lag 5.92 ± 0.10      
L. acidophilus LA-5 
ODmax 0.72 ± 0.01 NG 0.75 ± 0.02 0.48 ± 0.01 NG NG 
µmax 0.11 ± 0.01  0.07 ± 0.00 0.02 ± 0.00   
lag 7.92 ± 0.09  40.20 ± 0.50 20.23 ± 0.56   
L. rhamnosus GR-1 
ODmax 1.29 ± 0.06 0.82 ± 0.02 NG 1.03 ± 0.01 NG NG 
µmax 0.23 ± 0.01 0.09 ± 0.01  0.09 ± 0.00   
lag 2.07 ± 0.16 4.65 ± 0.41  2.11 ± 0.01   
L. casei LC-01 
ODmax 0.90 ± 0.03 0.51 ± 0.03 0.79 ± 0.01 0.48 ± 0.03 NG NG 
µmax 0.12 ± 0.00 0.06 ± 0.01 0.06 ± 0.00 0.04 ± 0.00   
lag 3.50 ± 0.04 3.15 ± 0.11 5.75 ± 0.02 1.18 ± 0.04   
Data represent means +/- SD of at least 2 replicates. NG: no growth.  432 
21 
 
Table 2. Growth (OD600) of Bifidobacterium strains with glucose, lactulose, lactosucrose and synthesized oligosaccharides as carbon sources. 433 
 434 
 B. lactis BB-12  B. breve 26M2  B. bifidum HDD541 
 24 h 48 h  24 h 48 h  24 h 48 h 
Glucose 1.11 ± 0.01 1.10 ± 0.12  0.79 ± 0.02 0.75 ± 0.01  0.76 ± 0.03 0.66 ± 0.02 
Lactulose 0.69 ± 0.02 1.08 ± 0.01  0.69 ± 0.03 0.89 ± 0.07  NG NG 
Lactosucrose 0.55 ± 0.01 0.73 ± 0.02  1.03 ± 0.01 1.04 ± 0.04  NG NG 
Kojibiose NG NG  1.20 ± 0.02 0.91 ± 0.01  NG NG 
Lactulosucrose 0.76 ± 0.05 0.70 ± 0.01  1.21 ± 0.02 0.84 ± 0.01  1.08 ± 0.06 0.49 ± 0.02 
4’-galactosyl-kojibiose NG NG  0.72 ± 0.03 0.55 ± 0.01  NG NG 
Data represent means +/- SD of at least 2 replicates. NG: no growth. 435 
22 
 
Figure legends. 436 
Figure 1. Chemical structures of the studied oligosaccharides. A) lactulose; B) 437 
lactosucrose; C) kojibiose; D) lactulosucrose; E) 4’-galactosyl-kojibiose. 438 
Figure 2. Growth curves of the bacterial strains on A) kojibiose and B) lactosucrose. 439 
  440 
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